|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


* Department of Pharmacokinetics and Drug Metabolism, Allergan, Inc., 2525 Dupont Drive, P.O. Box 19534, Irvine, CA 92623
** Department of Biological Sciences, Allergan, Inc., 2525 Dupont Drive, P.O. Box 19534, Irvine, CA 92623
Department of Medicinal Chemistry, Allergan, Inc., 2525 Dupont Drive, P.O. Box 19534, Irvine, CA 92623
The Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037
1 To whom correspondence should be addressed. e-mail: weber_allan{at}allergan.com
We investigated the formation of PGF2
1-ethanolamide, PGE2 1-ethanolamide, and PGD2 1-ethanolamide (prostamides F2
, E2, and D2, respectively) in liver, lung, kidney, and small intestine after a single intravenous bolus administration of 50 mg/kg of anandamide to normal and fatty acid amide hydrolase knockout (FAAH -/-) male mice. One group of three normal mice was not dosed (naïve) while another group of three normal mice received a bolus intravenous injection of 50 mg/kg of anandamide. Three FAAH -/- mice also received an intravenous injection of 50 mg/kg of anandamide. After 30 min, the lung, liver, kidney, and small intestine were harvested and processed by liquid-liquid extraction. The concentrations of prostamide F2
, prostamide E2, prostamide D2, and anandamide were determined by HPLC-tandem mass spectrometry. Prostamide F2
was detected in tissues in FAAH -/- mice after administration of anandamide. Concentrations of anandamide, prostamide E2, and prostamide D2 in liver, kidney, lung, and small intestine were much higher in the anandamide-treated FAAH -/- mice than those of the anandamide-treated control mice.
This report demonstrates that prostamides, including prostamide F2
, were formed in vivo from anandamide, potentially by the cyclooxygenase-2 pathway when the competing FAAH pathway is lacking.
Abbreviations: COX-2, cyclooxygenase-2; FAAH, fatty acid amide hydrolase; FAAH -/-, FAAH knockout; HPLC-MS/MS, HPLC tandem mass spectrometry; LC-MS/MS, liquid chromatography-MS/MS; MRM, multiple-reaction monitoring; prostamide D2, PGD2 1-ethanolamide; prostamide E2, PGE2 1-ethanolamide; prostamide F2
, PGF2
1-ethanolamide
Supplementary key words anandamide cyclooxygenase-2 fatty acid amide hydrolase high-performance liquid chromatography PGD2 1-ethanolamide PGE2 1-ethanolamide PGF2
1-ethanolamide prostamide D2 prostamide E2 prostamide F2
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. A. Rouzer and L. J. Marnett Non-redundant Functions of Cyclooxygenases: Oxygenation of Endocannabinoids J. Biol. Chem., March 28, 2008; 283(13): 8065 - 8069. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Moriuchi, N. Koda, E. Okuda-Ashitaka, H. Daiyasu, K. Ogasawara, H. Toh, S. Ito, D. F. Woodward, and K. Watanabe Molecular Characterization of a Novel Type of Prostamide/Prostaglandin F Synthase, Belonging to the Thioredoxin-like Superfamily J. Biol. Chem., January 11, 2008; 283(2): 792 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Batkai, M. Rajesh, P. Mukhopadhyay, G. Hasko, L. Liaudet, B. F. Cravatt, A. Csiszar, Z. Ungvari, and P. Pacher Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H909 - H918. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Jhaveri, D. Richardson, D. A. Kendall, D. A. Barrett, and V. Chapman Analgesic Effects of Fatty Acid Amide Hydrolase Inhibition in a Rat Model of Neuropathic Pain J. Neurosci., December 20, 2006; 26(51): 13318 - 13327. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Glaser, S. J. Gatley, and A. N. Gifford Ex Vivo Imaging of Fatty Acid Amide Hydrolase Activity and Its Inhibition in the Mouse Brain J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1088 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yang, J. Ni, D. F. Woodward, D. D-S. Tang-Liu, and K.-H. J. Ling Enzymatic formation of prostamide F2{alpha} from anandamide involves a newly identified intermediate metabolite, prostamide H2 J. Lipid Res., December 1, 2005; 46(12): 2745 - 2751. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Awumey, A. C. Howlett, and D. I. Diz Is there a role for anandamide in cardiovascular regulation? Insights from studies of endocannabinoid metabolism Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H520 - H521. [Full Text] [PDF] |
||||
![]() |
C. A. Rouzer and L. J. Marnett Glycerylprostaglandin Synthesis by Resident Peritoneal Macrophages in Response to a Zymosan Stimulus J. Biol. Chem., July 22, 2005; 280(29): 26690 - 26700. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Glass, J. Hong, T. A. Sato, and M. D. Mitchell Misidentification of prostamides as prostaglandins J. Lipid Res., July 1, 2005; 46(7): 1364 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Benito, W.-K. Kim, I. Chavarria, C. J. Hillard, K. Mackie, R. M. Tolon, K. Williams, and J. Romero A Glial Endogenous Cannabinoid System Is Upregulated in the Brains of Macaques with Simian Immunodeficiency Virus-Induced Encephalitis J. Neurosci., March 9, 2005; 25(10): 2530 - 2536. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Cravatt, A. Saghatelian, E. G. Hawkins, A. B. Clement, M. H. Bracey, and A. H. Lichtman Functional disassociation of the central and peripheral fatty acid amide signaling systems PNAS, July 20, 2004; 101(29): 10821 - 10826. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |